CS logo
small CS logo
Doktor Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi

Ankara, Turkey
Specialized hospital in Ankara
Demetevler, Vatan Cd., 06200 Yenimahalle/Ankara

About Doktor Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Amgen
3
Celgene
2
Merck Sharp & Dohme LLC
2
Genmab
1
Millennium Pharmaceuticals, Inc.
1
Takeda
1
Total Rows: 6

Clinical Trials at Doktor Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi


During the past decade, Doktor Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100112222111100000000111111Started TrialsCompleted Trails20152016201720182019202020210123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission
2013-04-24
2023-12-31
Active, not recruiting
472
A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant
2014-07-01
2025-06-25
Active, not recruiting
656
An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation
2015-12-30
2023-12-31
Active, not recruiting
319
A Study of Ixazomib, Given With Dexamethasone in Adults With Multiple Myeloma
2017-08-01
2021-11-26
Completed
122
Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
2019-09-30
2025-03-31
Recruiting
162
Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)
2018-10-05
2024-12-30
Active, not recruiting
732
Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)
2018-11-08
2024-09-28
Active, not recruiting
1,579
AMG 404 in Patients With Advanced Solid Tumors
2019-03-05
2023-11-03
Active, not recruiting
170

Rows per page:

1–10 of 10

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Doktor Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi" #1 sponsor was "Amgen" with 3 trials, followed by "Celgene" with 2 trials sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored, "Genmab" with 1 trials sponsored and "Millennium Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Doktor Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi" #1 collaborator was "AbbVie" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAmgen: 3Amgen: 3Celgene: 2Celgene: 2Merck Sharp & Dohme LLC: 2Merck Sharp & Dohme LLC: 2Genmab: 1Genmab: 1MillenniumPharmaceuticals, Inc.: 1MillenniumPharmaceuticals, Inc.: 1Takeda: 1Takeda: 1

Created with Highcharts 11.1.0Top CollaboratorsAbbVie: 1AbbVie: 1

Clinical Trials Conditions at Doktor Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi


According to Clinical.Site data, the most researched conditions in "Doktor Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi" are "Chemotherapy-induced Thrombocytopenia" (2 trials), "Advanced Solid Tumors" (1 trials), "Autologous Stem Cell Transplant" (1 trials), "Diffuse Large B-cell Lymphoma" (1 trials) and "Gastric Neoplasms" (1 trials). Many other conditions were trialed in "Doktor Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi" in a lesser frequency.

Clinical Trials Intervention Types at Doktor Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi


Most popular intervention types in "Doktor Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi" are "Drug" (9 trials), "Biological" (4 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Cisplatin" (2 trials), "Pembrolizumab" (2 trials), "Romiplostim" (2 trials) and "5-FU" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Doktor Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi


The vast majority of trials in "Doktor Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi" are 10 trials for "All" genders.

Clinical Trials Status at Doktor Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi


Currently, there are NaN active trials in "Doktor Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Doktor Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Doktor Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 8Phase 3: 8Phase 1: 1Phase 1: 1Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 6Active, not recruiting: 6Recruiting: 3Recruiting: 3Completed: 1Completed: 1